Molecular docking is a cornerstone computational technique in structure-based drug design that predicts the three-dimensional structure of a protein-ligand complex and estimates the binding affinity.
This article provides a comprehensive exploration of the fundamental principles, methodologies, and contemporary applications of structure-based drug design (SBDD).
This article provides a comprehensive examination of the enthalpy-entropy compensation (EEC) phenomenon in biomolecular ligand binding, a critical consideration for researchers and drug developers aiming to optimize binding affinity.
This article provides a comprehensive exploration of hydrogen bonding and hydrophobic effects in protein-ligand docking, essential for structure-based drug design.
This article provides a comprehensive analysis of the lock-and-key, induced fit, and conformational selection models for protein-ligand recognition, tailored for researchers and drug development professionals.
This article provides a comprehensive overview of the physical principles underpinning molecular docking for researchers, scientists, and drug development professionals.
This article provides researchers, scientists, and drug development professionals with a comprehensive framework for evaluating virtual screening (VS) protocols.
This article provides a comprehensive guide for researchers and drug development professionals on the critical process of pharmacophore model validation.
This article provides a comprehensive comparative analysis of fragment screening methodologies essential for early-stage drug discovery.
This article provides a comprehensive assessment of AlphaFold's role in modern drug discovery for researchers and development professionals.